Ikena Oncology’s Acquisition of Pionyr Immunotherapeutics

Pietro Martinoia
Tagged:

Latham & Watkins advised Pionyr on the sale.Ikena Oncology, Inc. (Nasdaq: IKNA, Ikena) and Pionyr Immunotherapeutics, Inc. have announced the closing of Ikena’s acquisition of Pionyr…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now